header
Image from OpenLibrary

Plasma level of MiRNA-499 as an early biomarker in patients with acute decompensated heart failure / Talaat Hachem Ahmed ; Supervised Wafaa Anwar Elaroussy , Karim Said Mostafa , Neveen Mohamed Helmy

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Talaat Hachem Ahmed , 2019Description: 119 P. : charts , facsimiles ; 25cmOther title:
  • المستوى البلازمى للحمض النووى الريبوى متناهى الصغر ٤٩٩ كمؤشر حيوى مبكر فى مرضى هبوط عضلة القلب الحاد اللامعاوض [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Cardiology Summary: Background: MiRNAs (miRNAs) are endogenous small RNAs that are 21{u2013}25 nucleotides in length. Recently, plasma miRNAs have been reported to be sensitive and specific biomarkers of various tissue injuries and cardiovascular conditions. MiRNA-499 is a newly discovered member of the miRNAs, and is mainly expressed in the myocardium. The circulating miRNAs value has been extensively addressed in patients with acute coronary syndrome. However, prognostic performances of miRNAs in patients with acute decompensated heart failure (ADHF) has received less attention. Objectives: The purpose of this study is to identify the potential relationship between early plasma levels of miRNA-499, within the first 24 hours after hospital admission, and early plasma level of brain natriuretic peptide (BNP) in hospitalized patients with acute decompensated heart failure and its relation to the clinical outcomes. Patients and methods: A total 30 patients with acute decompensated heart failure were recruited in our study. Blood samples were collected within the first 24 hours of admission to the intensive care unit. The plasma concentrations of well-characterized miRNA (miRNA-499) was assessed by a real-time reverse transcription-polymerase chain reaction (PCR Test) for all patients using artificial small RNA (Cell-miRNA39) as an internal reference gene. The level of miRNA-499 expression was measured using the cycle threshold
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.04.M.Sc.2019.Ta.P (Browse shelf(Opens below)) Not for loan 01010110080826000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.04.M.Sc.2019.Ta.P (Browse shelf(Opens below)) 80826.CD Not for loan 01020110080826000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Cardiology

Background: MiRNAs (miRNAs) are endogenous small RNAs that are 21{u2013}25 nucleotides in length. Recently, plasma miRNAs have been reported to be sensitive and specific biomarkers of various tissue injuries and cardiovascular conditions. MiRNA-499 is a newly discovered member of the miRNAs, and is mainly expressed in the myocardium. The circulating miRNAs value has been extensively addressed in patients with acute coronary syndrome. However, prognostic performances of miRNAs in patients with acute decompensated heart failure (ADHF) has received less attention. Objectives: The purpose of this study is to identify the potential relationship between early plasma levels of miRNA-499, within the first 24 hours after hospital admission, and early plasma level of brain natriuretic peptide (BNP) in hospitalized patients with acute decompensated heart failure and its relation to the clinical outcomes. Patients and methods: A total 30 patients with acute decompensated heart failure were recruited in our study. Blood samples were collected within the first 24 hours of admission to the intensive care unit. The plasma concentrations of well-characterized miRNA (miRNA-499) was assessed by a real-time reverse transcription-polymerase chain reaction (PCR Test) for all patients using artificial small RNA (Cell-miRNA39) as an internal reference gene. The level of miRNA-499 expression was measured using the cycle threshold

Issued also as CD

There are no comments on this title.

to post a comment.